Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anastomotic Leak × Metronidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 4 Surgical Wound Infection 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Postoperative Complications 1 Persistence of Infection With Helicobacter Pylori 1 Mouth Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1 Leukemia, B-Cell 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Familial primary gastric lymphoma 1 Dysbiosis 1 Diverticulitis 1 Colonic Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Tomography, X-Ray Computed 2 Serum Albumin, Human 2 Indocyanine Green 2 Ileostomy 2 Esophagectomy 2 obsidian 1 Water 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Stents 1 Sodium Chloride 1 Saline Solution 1 Robotic Surgical Procedures 1 Proctoscopy 1 Proctectomy 1 Neomycin 1 Neoadjuvant Therapy 1 Negative-Pressure Wound Therapy 1 Mortality 1 Metronidazole 1 Marital Status 1 Laparotomy 1 Inulin 1 Hematologic Tests 1 Fibrin Tissue Adhesive 1 Endoscopy 1 Enbucrilate 1 Diathermy 1 Colistin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡